| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-13 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.27 | 3e-11 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.27 | 5e-11 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.27 | 5e-09 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.28 | 8e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |